Toscani, Denise

The osteoblastic niche in the context of multiple myeloma

Toscani, D., Bolzoni, M., Accardi, F., Aversa, F., & Giuliani, N. (2015) · Annals of the New York Academy of Sciences

Multiple Myeloma Research and TreatmentsHematopoietic Stem Cell Transplantation

Cited by 52

Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability

Chiu, M., Toscani, D., Marchica, V., Taurino, G., Costa, F., Bianchi, M. G., Andreoli, R., Franceschi, V., Storti, P., Burroughs-Garcia, J., et al. (2020) · Cancers

Multiple Myeloma Research and TreatmentsAmino Acid Enzymes and Metabolism

Cited by 42

The Metabolic Features of Osteoblasts: Implications for Multiple Myeloma (MM) Bone Disease

Lungu, O., Toscani, D., Burroughs-Garcia, J., & Giuliani, N. (2023) · International Journal of Molecular Sciences

Bone Metabolism and DiseasesMultiple Myeloma Research and Treatments

Cited by 10

Metabolic features of myeloma cells in the context of bone microenvironment: Implication for the pathophysiology and clinic of myeloma bone disease

Raimondi, V., Toscani, D., Marchica, V., Burroughs-Garcia, J., Storti, P., & Giuliani, N. (2022) · Frontiers in Oncology

Multiple Myeloma Research and TreatmentsCancer, Hypoxia, and Metabolism

Cited by 10

P-092: Impaired glutamine/glutamate metabolic axis into myeloma microenvironment affects osteoclast formation.

Toscani, D., Chiu, M., Raimondi, V., Iannozzi, N. T., Lungu, O., Garcia, J. B., Notarfranchi, L., Palma, B. A. D., Taurino, G., Bussolati, O., et al. (2022) · Clinical Lymphoma Myeloma and Leukemia

Multiple Myeloma Research and TreatmentsBone Metabolism and Diseases

Cited by 2